Inhibrx Biosciences, Inc. (NASDAQ:INBX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kimberly Manhard Other companies: Connect Biopharma Holdings Limited (CHIEF DEVELOPMENT OFFICER · Since at least Nov 5, 2026); Inhibrx Inc (Director · Aug 18, 2020 – May 30, 2024 · Past); Heron Therapeutics, Inc. (EVP, Drug Development · Jan 10, 2014 – Apr 13, 2023 · Past); Ardea Biosciences Inc (SVP, Regulatory & Dev Ops · Oct 28, 2011 – Jun 19, 2012 · Past) | Director · Since at least May 24, 2024 |
| Jon Faiz Kayyem Other companies: Biodesix, Inc. (Director · Since at least Jan 1, 2024); Inhibrx Inc (Director · May 30, 2024 – May 30, 2024 · Past) | Director · Since at least May 24, 2024 |
| Mark P. Lappe Other companies: Inhibrx Inc (Chief Executive Officer, Director · Aug 18, 2020 – May 30, 2024 · Past); Repros Therapeutics (Director · Sep 29, 2008 – May 20, 2009 · Past) | Founder, Chief Executive Officer · Since at least May 24, 2024 |
| Brendan P Eckelman Other companies: Inhibrx Inc (Chief Scientific Officer · Aug 18, 2020 – May 28, 2024 · Past) | Chief Scientific Officer · May 24, 2024 – May 29, 2024 · Past |
| Douglas G. Forsyth Other companies: Inhibrx Inc (Director · Aug 18, 2020 – May 30, 2024 · Past) | Director · Since at least May 24, 2024 |
| Ashraf Amanullah | EVP, Chief Technical Operations Officer · Since at least Nov 5, 2026 |
| Bonne Adams | VP, Operations · Since at least Nov 5, 2026 |
| Brian Lobo | VP, Formulation Development and Drug Product Manufacturing · Since at least Nov 5, 2026 |
| Carlos Bais | EVP, Chief Scientific Officer · Since at least Apr 1, 2025 |
| Dana Ebbets-Reed | VP, Quality Assurance · Since at least Nov 5, 2026 |
| Darren Brown | VP, Analytical Development and Quality Control · Since at least Nov 5, 2026 |
| David Kao | VP, Regulatory Affairs · Since at least Nov 5, 2026 |
| David Matly | President · Since at least Apr 1, 2025 |
| Jon Faiz Kayyem | Director · Since at least Sep 23, 2026 |
| Josep Garcia | EVP, Chief Clinical Development Officer · Since at least Nov 4, 2025 |
| Kate Burke C.P.A. | VP, Accounting · Since at least Nov 4, 2026 |
| Kelly Deck | EVP, Chief Financial Officer · Since at least Apr 1, 2025 |
| Kristiina Vuori | Director · Since at least Nov 5, 2026 |
| Leah Pollema | VP, General Counsel · Since at least Nov 5, 2026 |
| Melissa Masterson | VP, Access and Commercialization · Since at least Nov 5, 2026 |
| Robert Boothroyd | VP, Medical Affairs and Business Development · Since at least Nov 5, 2026 |
| Sean Flanagan | VP, Sales · Since at least Nov 5, 2026 |